My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Cidara Therapeutics, Inc. - Common Stock (NQ:CDTX)

221.38 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Cidara Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Analyst Ratings for Cidara Therapeutics ↗

April 18, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 28, 2023

Via Benzinga

Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 28, 2023

Gainers

Via Benzinga

Why FreightCar America Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket ↗

March 28, 2023

Gainers Biodexa Pharmaceuticals (NASDAQ: BDRX) shares rose 76% to $0.8276 in pre-market trading after gaining 65% on Monday.

Via Benzinga

Cidara's Lower Than Expected Q4 Earnings Overshadows FDA Nod For Antifungal Treatment ↗

March 23, 2023

Via Benzinga

The Latest Analyst Ratings for Cidara Therapeutics ↗

March 23, 2023

Via Benzinga

Cidara Therapeutics And 2 Other Stocks Under $2 Insiders Are Aggressively Buying ↗

March 28, 2023

The Dow Jones closed higher by around 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 24, 2023

Via Benzinga

Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 24, 2023

Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50.

Via Benzinga

Dow Up 150 Points; Gold Jumps Over 2% ↗

March 23, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 150 points on Thursday. The Dow traded up 0.47% to 32,180.26 while the NASDAQ rose 1.29% to 11,820.77. The S&P...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 23, 2023

Via Benzinga

Nasdaq Surges Over 2%; Accenture To Reduce 19,000 Jobs ↗

March 23, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 450 points on Thursday. The Dow traded up 1.42% to 32,484.03 while the NASDAQ rose 2.40% to 11,949.60. The S&P 500,...

Via Benzinga

Accenture Layoffs 2023: What to Know About the Latest ACN Job Cuts ↗

March 23, 2023

Accenture (ACN) layoffs are a hot topic among traders on Thursday after the company announced a 2.5% cut to its workforce.

Via InvestorPlace

Why Is Cidara Therapeutics (CDTX) Stock Down 12% Today? ↗

March 23, 2023

Cidara Therapeutics (CDTX) stock is falling on Thursday despite the immunotherapy company getting positive news from the FDA.

Via InvestorPlace

Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 23, 2023

Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 23, 2023

Via Benzinga

Why Agile Therapeutics Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket ↗

March 23, 2023

Gainers ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) shares rose 82.8% to $2.98 in pre-market trading. ZyVersa Therapeutics recently reported new employment inducement grants under Nasdaq Listing Rule...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

March 23, 2023

We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Thursday morning!

Via InvestorPlace

Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 03, 2023

Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.

Via Benzinga

Why Heritage Insurance Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

March 03, 2023

Gainers ObsEva SA (NASDAQ: OBSV) rose 93.1% to $0.2047 in pre-market trading after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 03, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 03, 2023

We're starting off Friday morning with a breakdown of the biggest pre-market stock movers traders need to keep an eye on!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 02, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 01, 2023

Via Benzinga

Johnson & Johnson-Backed Antiviral Candidate Effectively Prevents Influenza Infection ↗

March 01, 2023

Cidara Therapeutics Inc (NASDAQ: CDTX) announced efficacy and safety data from a planned interim analysis of the ongoing Phase 2a trial evaluating the pre-exposure prophylactic activity of CD388...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 25, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 24, 2023

Via Benzinga

Why FARO Technologies Shares Are Trading Lower By 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 20, 2023

Gainers Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 133.1% to $0.2870. Helbiz recently announced discontinuation of operations in non-profitable markets.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 20, 2023

Via Benzinga

Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors ↗

December 27, 2022

Biopharma stocks were not immune to the broader market downturn seen for much of 2022.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.